Pharma analyst at Macquarie Research, Abhishek Singhal, spoke to CNBC-TV18 about the key takeaways from the management meet post Ranbaxy’s settlement with the US FDA.
first published: Dec 22, 2011 12:25 pm
A collection of the most-viewed Moneycontrol videos.

Live: Davos 2026 | Day 1 Highlights of World Economic Forum with Top Global Voices

Live: Nifty below 25,600 as heavyweights weigh, majority sectors in red | Closing Bell

Live: Can Nifty breach 25,900 after RIL, HDFC Bank Q3 results? | Opening Bell

Davos 2026: AI Will Consume Massive Energy! WEF’s Roberto Bocca Urges National Energy Security
You are already a Moneycontrol Pro user.

